Drifa Belhadi

MedicineEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Endpoints for randomized controlled clinical trials for COVID-19 treatments”.

Endpoints for randomized controlled clinical trials for COVID-19 treatments

Clinical Trials(2020)10.1177/1740774520939938

N/A

0DataRank · unranked

4 citations

Dean Follmann, Jing Wang, Franz Koenig, Lisa L. Korn, Christian Schoergenhofer +10 more

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00528-8

N/A

0DataRank · unranked

125 citations

Benjamin Speich, France Mentré, Corina S. Rueegg, Drifa Belhadi, Lambert Assoumou +30 more

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102472

N/A

0DataRank · unranked

8 citations

André C. Kalil, Drifa Belhadi, Viviane Cordeiro Veiga, Alexandre Biasi Cavalcanti, Westyn Branch‐Elliman +75 more